Gattaca says entering new financial year with momentum as income rises
(Alliance News) - Gattaca PLC on Monday said annual net fee income rose as it anticipates to deliver further improvements in pretax profit. Read More
| Price | 159.50p on 20-08-2026 at 18:25:09 |
|---|---|
| Change | -4.50p -2.74% |
| Buy | 163.00p |
| Sell | 156.00p |
| Last Trade: | Sell 600.00 at 158.00p |
| Day's Volume: | 9,105 |
| Last Close: | 159.50p |
| Open: | 164.00p |
| ISIN: | GB00B1FMDQ43 |
| Day's Range | 159.50p - 164.00p |
| 52wk Range: | 80.50p - 172.00p |
| Market Capitalisation: | £49.27m |
| VWAP: | 160.15484p |
| Shares in Issue: | 30.89m |
Sector: Industrial Services
Listed In: FTSE AIM All-Share,
Gattaca (GATC) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 600 | 158.00p | Ordinary |
15:33:20 - 20-Aug-26 |
| Sell* | 3 | 158.00p | SI Trade |
15:31:19 - 20-Aug-26 |
| Buy* | 22 | 163.00p | SI Trade |
15:31:19 - 20-Aug-26 |
| Sell* | 500 | 160.00p | Ordinary |
15:31:16 - 20-Aug-26 |
| Sell* | 2,750 | 160.675p | Ordinary |
14:42:31 - 20-Aug-26 |
| Sell* | 1,128 | 160.00p | Ordinary |
14:06:00 - 20-Aug-26 |
| Sell* | 100 | 160.675p | Ordinary |
11:38:48 - 20-Aug-26 |
| Buy* | 66 | 163.00p | Ordinary |
11:24:40 - 20-Aug-26 |
| Buy* | 1 | 162.97p | Ordinary |
11:06:10 - 20-Aug-26 |
| Buy* | 2 | 165.00p | SI Trade |
09:47:49 - 20-Aug-26 |
Gattaca (GATC) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 17th Aug 2026 7:00 am | RNS | Trading Update |
| 14th May 2026 7:00 am | RNS | Trading Update |
| 1st Apr 2026 7:00 am | RNS | BLOCK LISTING SIX MONTHLY RETURN |
| 24th Mar 2026 7:00 am | RNS | Interim Results |
| 11th Mar 2026 7:00 am | RNS | Notice of Results and Investor Presentations |
| 11th Mar 2026 7:00 am | RNS | Notice of Results and Investor Presentations |
| 11th Feb 2026 7:00 am | RNS | Trading Update |
| 31st Dec 2025 7:00 am | RNS | Director/PDMR dealing |
| 31st Dec 2025 7:00 am | RNS | Director/PDMR dealing |
| 19th Dec 2025 3:29 pm | RNS | Grant of Options and Director/PDMR dealing |